CN1166669C - Prepn process of sodium cantharidinate - Google Patents
Prepn process of sodium cantharidinate Download PDFInfo
- Publication number
- CN1166669C CN1166669C CNB021134901A CN02113490A CN1166669C CN 1166669 C CN1166669 C CN 1166669C CN B021134901 A CNB021134901 A CN B021134901A CN 02113490 A CN02113490 A CN 02113490A CN 1166669 C CN1166669 C CN 1166669C
- Authority
- CN
- China
- Prior art keywords
- cantharidin
- filtrate
- water
- acetone
- suction filtration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract 4
- 229910052708 sodium Inorganic materials 0.000 title abstract 4
- 239000011734 sodium Substances 0.000 title abstract 4
- DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 claims abstract description 20
- 229940095758 cantharidin Drugs 0.000 claims abstract description 20
- 229930008397 cantharidin Natural products 0.000 claims abstract description 20
- DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000002674 ointment Substances 0.000 claims abstract description 5
- 238000001953 recrystallisation Methods 0.000 claims abstract description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000000967 suction filtration Methods 0.000 claims description 12
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000012043 crude product Substances 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 5
- 241000623906 Lytta vesicatoria Species 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 239000003978 infusion fluid Substances 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000131283 Cantharis Species 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021134901A CN1166669C (en) | 2002-03-20 | 2002-03-20 | Prepn process of sodium cantharidinate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021134901A CN1166669C (en) | 2002-03-20 | 2002-03-20 | Prepn process of sodium cantharidinate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1374310A CN1374310A (en) | 2002-10-16 |
| CN1166669C true CN1166669C (en) | 2004-09-15 |
Family
ID=4742641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021134901A Expired - Lifetime CN1166669C (en) | 2002-03-20 | 2002-03-20 | Prepn process of sodium cantharidinate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1166669C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1190190C (en) * | 2001-11-23 | 2005-02-23 | 王卫 | Antiviral and antibacterial cantharidinic anhydride medicine composition and its prepn process |
| CN101108854B (en) * | 2007-07-27 | 2010-05-26 | 贵州大学 | A kind of cantharidin separation and purification method |
| CN101108853B (en) * | 2007-07-27 | 2010-05-26 | 贵州大学 | Cantharidin separation and purification method |
| CN102146086B (en) * | 2011-04-12 | 2012-03-07 | 贵州金桥药业有限公司 | Preparation method of sodium cantharidate |
| CN102268006B (en) * | 2011-06-15 | 2013-08-14 | 北京联合大学生物化学工程学院 | Method for extracting cantharidin from compound enzyme |
| CN102276619A (en) * | 2011-06-21 | 2011-12-14 | 贵州金桥药业有限公司 | Method for preparing sodium canthanridate |
| CN102336765A (en) * | 2011-10-11 | 2012-02-01 | 江苏四环生物股份有限公司 | Method for extracting cantharidin from cantharides |
| CN102796794A (en) * | 2012-08-31 | 2012-11-28 | 哈尔滨工业大学 | Preparation method of cantharis toxin |
| CN103479642B (en) * | 2013-09-30 | 2015-04-29 | 贵州金桥药业有限公司 | Nano sodium cantharidinate composition and preparation method thereof |
| CN107936036A (en) * | 2017-11-29 | 2018-04-20 | 贵州柏强制药有限公司 | A kind of disodium cantharidinate and preparation method thereof |
-
2002
- 2002-03-20 CN CNB021134901A patent/CN1166669C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1374310A (en) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101643466B (en) | Epigallo-catechin gallate (EGCG) with high purity and preparation method thereof | |
| EP2573070A1 (en) | Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof | |
| CN1166669C (en) | Prepn process of sodium cantharidinate | |
| CN100545164C (en) | Preparation process of sodium cantharidate | |
| CN100497343C (en) | Method for preparing ellagic acid by pomegranate rind | |
| CN102010454B (en) | Citicoline sodium compound and new method thereof | |
| JP6159480B2 (en) | Preparation of (-)-Huperzine A | |
| CN112209988B (en) | Tea sapogenin thiosemicarbazone zinc complex and preparation method and application thereof | |
| CN102846600A (en) | Oxiracetam drug activity composition and preparation method thereof | |
| CN103073542A (en) | Preparation method and application of tropisetron citrate crystal form II | |
| CN102166260B (en) | Clove extract with tumor resisting effect and pharmaceutical preparation thereof | |
| CN103804433A (en) | Refining method of lactose | |
| CN102093250A (en) | Glutamine dipeptide compound and novel method thereof | |
| CN1456257B (en) | Fresh motherwort particle preparing method | |
| CN100415228C (en) | Medicine containing galangin and preparation method thereof | |
| CN100554261C (en) | A kind of preparation method of ampelopsin | |
| CN100486988C (en) | Process for preparing 20(R)-ginsenoside Rh2 | |
| CN103073543A (en) | Preparation method and application of tropisetron citrate crystal form I | |
| CN1345728A (en) | Solasodine hydrochlorate and productive method and application in medicine | |
| CN109467581B (en) | Method for extracting flavonoid glycoside from lotus leaves and pharmaceutical preparation containing flavonoid glycoside from lotus leaves | |
| CN102408458A (en) | Production process for refining glucosamine hydrochloride by membrane separation method | |
| CN102786418A (en) | Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products | |
| CN101633639B (en) | High-purity fleroxacin compound | |
| CN113429452A (en) | Acylated mogroside derivatives as anti-inflammatory agents and anti-inflammatory compositions | |
| CN105148124A (en) | Composition with anti-tumor function and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Guizhou Baiqiang Pharmaceutical Co., Ltd. Assignor: Guizhou Junzhitang Pharmaceutical Co., Ltd. Contract record no.: 2011520000004 Denomination of invention: Preparing process of sodium cantharidinate Granted publication date: 20040915 License type: Exclusive License Open date: 20021016 Record date: 20110725 |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170616 Address after: 550002 N-10, industrial zone, Nanming District, Guizhou, Guiyang Patentee after: Guizhou Baiqiang Pharmaceutical Co., Ltd. Address before: 550001 No. 85 Zhonghua Road, Guiyang, Guizhou Patentee before: Guizhou Junzhitang Pharmaceutical Co., Ltd. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040915 |